Holen Sie sich die Stockscreener-App
5.59
1.27%
0.07
Schlusskurs vom Vortag:
$5.52
Offen:
$5.5
24-Stunden-Volumen:
430.21K
Relative Volume:
0.83
Marktkapitalisierung:
$281.69M
Einnahmen:
$230.47M
Nettoeinkommen (Verlust:
$30.28M
KGV:
9.1639
EPS:
0.61
Netto-Cashflow:
$38.86M
1W Leistung:
+7.71%
1M Leistung:
+18.18%
6M Leistung:
+55.28%
1J Leistung:
+85.10%
1-Tages-Spanne:
$5.435
$5.669
1-Wochen-Bereich:
$5.16
$5.669
52-Wochen-Spanne:
$2.575
$6.12
Puma Biotechnology Inc Stock (PBYI) Company Profile
Firmenname
Puma Biotechnology Inc
Sektor
Branche
Telefon
(424) 248-6500
Adresse
10880 WILSHIRE BLVD., LOS ANGELES, CA
Vergleichen Sie PBYI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBYI
Puma Biotechnology Inc
|
5.59 | 278.16M | 230.47M | 30.28M | 38.86M | 0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-09-28 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-06-25 | Fortgesetzt | BofA/Merrill | Underperform |
| 2019-10-08 | Herabstufung | Goldman | Neutral → Sell |
| 2019-05-10 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2019-01-17 | Eingeleitet | Leerink Partners | Mkt Perform |
| 2019-01-03 | Herabstufung | Guggenheim | Buy → Neutral |
| 2018-11-19 | Hochstufung | Goldman | Sell → Neutral |
| 2018-11-02 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2018-11-02 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-10-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-09-17 | Eingeleitet | Goldman | Sell |
| 2018-05-11 | Bestätigt | Stifel | Buy |
| 2017-11-10 | Bestätigt | Citigroup | Buy |
| 2017-11-10 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-10-02 | Bestätigt | Stifel | Buy |
| 2017-09-11 | Bestätigt | Credit Suisse | Outperform |
| 2017-07-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2017-06-06 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-05-25 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2017-03-02 | Bestätigt | RBC Capital Mkts | Sector Perform |
Alle ansehen
Puma Biotechnology Inc Aktie (PBYI) Neueste Nachrichten
What analysts say about Puma Biotechnology Inc stockStock Liquidity Analysis & Minimal Investment Capital Gains - earlytimes.in
Can Puma Biotechnology Stock Hold Up When Markets Turn? - Trefis
What insider trading reveals about Puma Biotechnology Inc. stock2025 Top Gainers & Daily Oversold Bounce Ideas - Newser
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - PharmiWeb.com
Puma Biotechnology (NASDAQ:PBYI) Stock Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
With 60% ownership of the shares, Puma Biotechnology, Inc. (NASDAQ:PBYI) is heavily dominated by institutional owners - Yahoo Finance
Puma Biotechnology, Inc. (PBYI) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
What dividend safety score for Puma Biotechnology Inc. stockPortfolio Growth Summary & Precise Buy Zone Tips - moha.gov.vn
Total debt per share of Puma Biotechnology, Inc. – TRADEGATE:0PB - TradingView
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick? - sharewise.com
Check out these key findings about Puma Biotechnology Inc (PBYI) - Setenews
Hillsdale Investment Management Inc. Makes New Investment in Puma Biotechnology, Inc. $PBYI - MarketBeat
Will Puma Biotechnology Inc. stock continue upward momentumGDP Growth & AI Forecast Swing Trade Picks - newser.com
Is Puma Biotechnology Inc. stock affected by interest rate hikes2025 Earnings Impact & Real-Time Volume Surge Alerts - newser.com
Using Ichimoku Cloud for Puma Biotechnology Inc. technicalsJuly 2025 Short Interest & Fast Entry and Exit Trade Plans - newser.com
Using data filters to optimize entry into Puma Biotechnology Inc.July 2025 Drop Watch & Intraday High Probability Alerts - newser.com
Published on: 2025-11-19 05:37:08 - newser.com
Using fundamentals and technicals on Puma Biotechnology Inc.Trend Reversal & Stepwise Trade Execution Plans - newser.com
Adversity is less terrifying than hope: Puma Biotechnology Inc (PBYI) - Setenews
1stdibs.Com And 2 Other Penny Stocks To Watch Closely - simplywall.st
Puma Biotechnology, Inc.Corporate Presentation, November 2025 (11/17/2025 10: 08 - MarketScreener
How strong is Puma Biotechnology Inc. stock revenue growthWeekly Trade Review & Capital Protection Trading Alerts - newser.com
Using R and stats models for Puma Biotechnology Inc. forecastingJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - newser.com
Published on: 2025-11-18 22:41:28 - newser.com
Published on: 2025-11-14 15:23:18 - newser.com
Can Puma Biotechnology Inc. stock withstand economic slowdownMarket Activity Summary & Entry Point Strategy Guides - newser.com
Why retail investors favor Puma Biotechnology Inc. stock2025 Growth vs Value & Weekly Breakout Watchlists - Fundação Cultural do Pará
Aug Final Week: Is Puma Biotechnology Inc. stock a safe buy before earnings - Fundação Cultural do Pará
Finanzdaten der Puma Biotechnology Inc-Aktie (PBYI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):